Skip to main content

Procedure for Gastric Variceal Bleeding: From BRTO to PARTO to CARTO, Three Decades of Progress

  • Chapter
  • First Online:
Liver Diseases

Abstract

Gastric varices are less common than esophageal varices. However, it is known to be associated with a poor prognosis and mortality due to its high propensity to bleed massively. There are several management options for gastric variceal bleeding including medical management, endoscopic treatment, transjugular intrahepatic portosystemic shunt, shunt surgery, and liver transplantation. However, clinical outcomes and recurrent bleeding rate of these current treatments are widely varying, and an alternative treatment method for gastric variceal bleeding is needed. In this chapter, we present a relatively novel treatment option for gastric varices called BRTO (Balloon-occluded retrograde transvenous obliteration) and its modified methods. In brief, BRTO and modified BRTO (PARTO = plug-assisted or CARTO = coil-assisted retrograde transvenous obliteration) appear safe and effective treatment options for gastric variceal bleeding.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 99.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 129.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 179.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

References

  1. Gwon DI, Ko GY, Yoon HK, et al. Gastric varices and hepatic encephalopathy: treatment with vascular plug and gelatin sponge-assisted retrograde transvenous obliteration--a primary report. Radiology. 2013;268:281–7.

    Article  PubMed  Google Scholar 

  2. Kim DJ, Darcy MD, Mani NB, et al. Modified balloon-occluded retrograde transvenous obliteration (BRTO) techniques for the treatment of gastric varices: vascular plug-assisted retrograde transvenous obliteration (PARTO)/coil-assisted retrograde transvenous obliteration (CARTO)/balloon-occluded antegrade transvenous obliteration (BATO). Cardiovasc Intervent Radiol. 2018;41:835–47.

    Article  PubMed  Google Scholar 

  3. Lee EW, Saab S, Gomes AS, et al. Coil-assisted retrograde transvenous obliteration (CARTO) for the treatment of portal hypertensive variceal bleeding: preliminary results. Clin Transl Gastroenterol. 2014;5:e61.

    Article  PubMed  PubMed Central  Google Scholar 

  4. Kanagawa H, Mima S, Kouyama H, et al. Treatment of gastric fundal varices by balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 1996;11:51–8.

    Article  CAS  PubMed  Google Scholar 

  5. Lee EW, Saab S, Kaldas F, et al. Coil-assisted retrograde transvenous obliteration (CARTO): an alternative treatment option for refractory hepatic encephalopathy. Am J Gastroenterol. 2018;113:1187.

    Article  PubMed  Google Scholar 

  6. Saad WE. The history and evolution of balloon-occluded retrograde transvenous obliteration (BRTO): from the United States to Japan and back. Semin Intervent Radiol. 2011;28:283–7.

    Article  PubMed  PubMed Central  Google Scholar 

  7. Arai H, Abe T, Shimoda R, et al. Emergency balloon-occluded retrograde transvenous obliteration for gastric varices. J Gastroenterol. 2005;40:964–71.

    Article  PubMed  Google Scholar 

  8. Park JK, Saab S, Kee ST, et al. Balloon-occluded retrograde transvenous obliteration (BRTO) for treatment of gastric varices: review and meta-analysis. Dig Dis Sci. 2015;60:1543.

    Article  PubMed  Google Scholar 

  9. Olson E, Yune HY, Klatte EC. Transrenal-vein reflux ethanol sclerosis of gastroesophageal varices. AJR Am J Roentgenol. 1984;143:627–8.

    Article  CAS  PubMed  Google Scholar 

  10. Kim SK, Lee KA, Sauk S, et al. Comparison of transjugular intrahepatic portosystemic shunt with covered stent and balloon-occluded retrograde transvenous obliteration in managing isolated gastric varices. Korean J Radiol. 2017;18:345–54.

    Article  PubMed  PubMed Central  Google Scholar 

  11. Saad WE, Darcy MD. Transjugular intrahepatic portosystemic shunt (TIPS) versus balloon-occluded retrograde transvenous obliteration (BRTO) for the management of gastric varices. Semin Intervent Radiol. 2011;28:339–49.

    Article  PubMed  PubMed Central  Google Scholar 

  12. Ryan BM, Stockbrugger RW, Ryan JM. A pathophysiologic, gastroenterologic, and radiologic approach to the management of gastric varices. Gastroenterology. 2004;126:1175–89.

    Article  PubMed  Google Scholar 

  13. Saad WE. Balloon-occluded retrograde transvenous obliteration of gastric varices: concept, basic techniques, and outcomes. Semin Intervent Radiol. 2012;29:118–28.

    Article  PubMed  PubMed Central  Google Scholar 

  14. Saad WE, Simon PO Jr, Rose SC. Balloon-occluded retrograde transvenous obliteration of gastric varices. Cardiovasc Intervent Radiol. 2014;37:299–315.

    Article  PubMed  Google Scholar 

  15. Chao Y, Lin HC, Lee FY, et al. Hepatic hemodynamic features in patients with esophageal or gastric varices. J Hepatol. 1993;19:85–9.

    Article  CAS  PubMed  Google Scholar 

  16. de Franchis R, Primignani M. Natural history of portal hypertension in patients with cirrhosis. Clin Liver Dis. 2001;5:645–63.

    Article  PubMed  Google Scholar 

  17. Garcia-Pagan JC, Barrufet M, Cardenas A, et al. Management of gastric varices. Clin Gastroenterol Hepatol. 2014;12:919.

    Article  PubMed  Google Scholar 

  18. Lopera JE. Gastric varices. Radiographics. 2013;33:100–1.

    Article  PubMed  Google Scholar 

  19. Laleman W, Simon-Talero M, Maleux G, et al. Embolization of large spontaneous portosystemic shunts for refractory hepatic encephalopathy: a multicenter survey on safety and efficacy. Hepatology. 2013;57:2448–57.

    Article  PubMed  Google Scholar 

  20. Cho SK, Shin SW, Lee IH, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices: outcomes and complications in 49 patients. AJR Am J Roentgenol. 2007;189:W365–72.

    Article  PubMed  Google Scholar 

  21. Binmoeller KF, Borsatto R. Variceal bleeding and portal hypertension. Endoscopy. 2000;32:189–99.

    Article  CAS  PubMed  Google Scholar 

  22. Segawa M, Sakaida I. Diagnosis and treatment of portal hypertension. Hepatol Res. 2009;39:1039–43.

    Article  PubMed  Google Scholar 

  23. Toubia N, Sanyal AJ. Portal hypertension and variceal hemorrhage. Med Clin North Am. 2008;92:551–74, viii.

    Article  PubMed  Google Scholar 

  24. Turon F, Casu S, Hernandez-Gea V, et al. Variceal and other portal hypertension related bleeding. Best Pract Res Clin Gastroenterol. 2013;27:649–64.

    Article  PubMed  Google Scholar 

  25. Kirby JM, Cho KJ, Midia M. Image-guided intervention in management of complications of portal hypertension: more than TIPS for success. Radiographics. 2013;33:1473–96.

    Article  PubMed  Google Scholar 

  26. Ninoi T, Nakamura K, Kaminou T, et al. TIPS versus transcatheter sclerotherapy for gastric varices. AJR Am J Roentgenol. 2004;183:369–76.

    Article  PubMed  Google Scholar 

  27. Maruyama H, Yokosuka O. Current management of gastric varices. JNMA J Nepal Med Assoc. 2007;46:143–50.

    CAS  PubMed  Google Scholar 

  28. Sarin SK, Agarwal SR. Gastric varices and portal hypertensive gastropathy. Clin Liver Dis. 2001;5:727–67, x.

    Article  CAS  PubMed  Google Scholar 

  29. Sarin SK, Lahoti D, Saxena SP, et al. Prevalence, classification and natural history of gastric varices: a long-term follow-up study in 568 portal hypertension patients. Hepatology. 1992;16:1343–9.

    Article  CAS  PubMed  Google Scholar 

  30. Yoshida H, Mamada Y, Taniai N, et al. Treatment modalities for bleeding esophagogastric varices. J Nippon Med Sch. 2012;79:19–30.

    Article  PubMed  Google Scholar 

  31. Ali SM, Wu S, Xu H, et al. A prospective study of endoscopic injection sclerotherapy and endoscopic variceal ligation in the treatment of esophageal varices. J Laparoendosc Adv Surg Tech A. 2017;27:333–41.

    Article  PubMed  Google Scholar 

  32. Emori K, Toyonaga A, Oho K, et al. Balloon-occluded retrograde transvenous obliteration versus endoscopic injection sclerotherapy for isolated gastric varices: a comparative study. Kurume Med J. 2014;60:105–13.

    Article  PubMed  Google Scholar 

  33. Caldwell S. Gastric varices: is there a role for endoscopic cyanoacrylates, or are we entering the BRTO era? Am J Gastroenterol. 2012;107:1784–90.

    Article  PubMed  Google Scholar 

  34. Al-Osaimi AM, Caldwell SH. Medical and endoscopic management of gastric varices. Semin Intervent Radiol. 2011;28:273–82.

    Article  PubMed  PubMed Central  Google Scholar 

  35. Hong CH, Kim HJ, Park JH, et al. Treatment of patients with gastric variceal hemorrhage: endoscopic N-butyl-2-cyanoacrylate injection versus balloon-occluded retrograde transvenous obliteration. J Gastroenterol Hepatol. 2009;24:372–8.

    Article  PubMed  Google Scholar 

  36. Huang YH, Yeh HZ, Chen GH, et al. Endoscopic treatment of bleeding gastric varices by N-butyl-2-cyanoacrylate (Histoacryl) injection: long-term efficacy and safety. Gastrointest Endosc. 2000;52:160–7.

    Article  CAS  PubMed  Google Scholar 

  37. Akahoshi T, Hashizume M, Tomikawa M, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric variceal bleeding and risky gastric varices: a 10-year experience. J Gastroenterol Hepatol. 2008;23:1702–9.

    Article  PubMed  Google Scholar 

  38. Akahoshi T, Tomikawa M, Kamori M, et al. Impact of balloon-occluded retrograde transvenous obliteration on management of isolated fundal gastric variceal bleeding. Hepatol Res. 2012;42:385–93.

    Article  PubMed  Google Scholar 

  39. Fukuda T, Hirota S, Sugimura K. Long-term results of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy. J Vasc Interv Radiol. 2001;12:327–36.

    Article  CAS  PubMed  Google Scholar 

  40. Hirota S, Matsumoto S, Tomita M, et al. Retrograde transvenous obliteration of gastric varices. Radiology. 1999;211:349–56.

    Article  CAS  PubMed  Google Scholar 

  41. Sonomura T, Ono W, Sato M, et al. Three benefits of microcatheters for retrograde transvenous obliteration of gastric varices. World J Gastroenterol. 2012;18:1373–8.

    Article  PubMed  PubMed Central  Google Scholar 

  42. Kobayakawa M, Kokubu S, Hirota S, et al. Short-term safety and efficacy of balloon-occluded retrograde transvenous obliteration using ethanolamine oleate: results of a prospective, multicenter, single-arm trial. J Vasc Interv Radiol. 2017;28:1108–1115 e2.

    Article  PubMed  Google Scholar 

  43. Chu HH, Kim M, Kim HC, et al. Long-term outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: a comparison of ethanolamine oleate and sodium tetradecyl sulfate. Cardiovasc Intervent Radiol. 2018;41:578–86.

    Article  PubMed  Google Scholar 

  44. Gwon DI, Kim YH, Ko GY, et al. Vascular plug-assisted retrograde transvenous obliteration for the treatment of gastric varices and hepatic encephalopathy: a prospective multicenter study. J Vasc Interv Radiol. 2015;26:1589–95.

    Article  PubMed  Google Scholar 

  45. Saad WE, Kitanosono T, Koizumi J, et al. The conventional balloon-occluded retrograde transvenous obliteration procedure: indications, contraindications, and technical applications. Tech Vasc Interv Radiol. 2013;16:101–51.

    Article  PubMed  Google Scholar 

  46. Saad WE, Sabri SS. Balloon-occluded retrograde transvenous obliteration (BRTO): technical results and outcomes. Semin Intervent Radiol. 2011;28:333–8.

    Article  PubMed  PubMed Central  Google Scholar 

  47. Sabri SS, Saad WE. Balloon-occluded retrograde transvenous obliteration (BRTO): technique and intraprocedural imaging. Semin Intervent Radiol. 2011;28:303–13.

    Article  PubMed  PubMed Central  Google Scholar 

  48. Chang MY, Kim MD, Kim T, et al. Plug-assisted retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage. Korean J Radiol. 2016;17:230–8.

    Article  PubMed  PubMed Central  Google Scholar 

  49. Kim YH, Kim YH, Kim CS, et al. Comparison of balloon-occluded retrograde transvenous obliteration (BRTO) using ethanolamine oleate (EO), BRTO using sodium tetradecyl sulfate (STS) foam and vascular plug-assisted retrograde transvenous obliteration (PARTO). Cardiovasc Intervent Radiol. 2016;39:840–6.

    Article  PubMed  Google Scholar 

  50. Sabri SS, Swee W, Turba UC, et al. Bleeding gastric varices obliteration with balloon-occluded retrograde transvenous obliteration using sodium tetradecyl sulfate foam. J Vasc Interv Radiol. 2011;22:309–16; quiz 316.

    Article  PubMed  Google Scholar 

  51. Gandini R, Chiocchi M, Konda D, et al. Transcatheter foam sclerotherapy of symptomatic female varicocele with sodium-tetradecyl-sulfate foam. Cardiovasc Intervent Radiol. 2008;31:778–84.

    Article  PubMed  Google Scholar 

  52. Yamaki T, Nozaki M, Sakurai H, et al. Prospective randomized efficacy of ultrasound-guided foam sclerotherapy compared with ultrasound-guided liquid sclerotherapy in the treatment of symptomatic venous malformations. J Vasc Surg. 2008;47:578–84.

    Article  PubMed  Google Scholar 

  53. Kessler J, Trerotola SO. Use of the Amplatzer Vascular Plug for embolization of a large retroperitoneal shunt during transjugular intrahepatic portosystemic shunt creation for gastric variceal bleeding. J Vasc Interv Radiol. 2006;17:135–40.

    Article  PubMed  Google Scholar 

  54. Yoo H, Ko GY, Gwon DI, et al. Preoperative portal vein embolization using an amplatzer vascular plug. Eur Radiol. 2009;19:1054–61.

    Article  PubMed  Google Scholar 

  55. Park JK, Cho SK, Kee S, et al. Vascular plug-assisted retrograde transvenous obliteration of portosystemic shunts for refractory hepatic encephalopathy: a case report. Case Rep Radiol. 2014;2014:391420.

    PubMed  PubMed Central  Google Scholar 

  56. Itou C, Koizumi J, Hashimoto T, et al. Balloon-occluded retrograde transvenous obliteration for the treatment of gastric varices: polidocanol foam versus liquid ethanolamine oleate. AJR Am J Roentgenol. 2015;205:659–66.

    Article  PubMed  Google Scholar 

  57. Jang SY, Kim GH, Park SY, et al. Clinical outcomes of balloon-occluded retrograde transvenous obliteration for the treatment of gastric variceal hemorrhage in Korean patients with liver cirrhosis: a retrospective multicenter study. Clin Mol Hepatol. 2012;18:368–74.

    Article  PubMed  PubMed Central  Google Scholar 

  58. Kiyosue H, Tanoue S, Kondo Y, et al. Balloon-occluded retrograde transvenous obliteration of complex gastric varices assisted by temporary balloon occlusion of the splenic artery. J Vasc Interv Radiol. 2011;22:1045–8.

    Article  PubMed  Google Scholar 

  59. Ninoi T, Nishida N, Kaminou T, et al. Balloon-occluded retrograde transvenous obliteration of gastric varices with gastrorenal shunt: long-term follow-up in 78 patients. AJR Am J Roentgenol. 2005;184:1340–6.

    Article  PubMed  Google Scholar 

  60. Rossle M, Piotraschke J. Transjugular intrahepatic portosystemic shunt and hepatic encephalopathy. Dig Dis. 1996;14(Suppl 1):12–9.

    Article  PubMed  Google Scholar 

  61. Kumamoto M, Toyonaga A, Inoue H, et al. Long-term results of balloon-occluded retrograde transvenous obliteration for gastric fundal varices: hepatic deterioration links to portosystemic shunt syndrome. J Gastroenterol Hepatol. 2010;25:1129–35.

    Article  PubMed  Google Scholar 

  62. Saad WE, Wagner CC, Al-Osaimi A, et al. The effect of balloon-occluded transvenous obliteration of gastric varices and gastrorenal shunts on the hepatic synthetic function: a comparison between Child-Pugh and model for end-stage liver disease scores. Vasc Endovascular Surg. 2013;47:281–7.

    Article  PubMed  Google Scholar 

  63. Mukund A, Rajesh S, Arora A, et al. Efficacy of balloon-occluded retrograde transvenous obliteration of large spontaneous lienorenal shunt in patients with severe recurrent hepatic encephalopathy with foam sclerotherapy: initial experience. J Vasc Interv Radiol. 2012;23:1200–6.

    Article  PubMed  Google Scholar 

  64. Suraweera D, Sundaram V, Saab S. Evaluation and management of hepatic encephalopathy: current status and future directions. Gut Liver. 2016;10:509–19.

    Article  PubMed  PubMed Central  Google Scholar 

  65. Kasuga A, Mizumoto H, Matsutani S, et al. Portal hemodynamics and clinical outcomes of patients with gastric varices after balloon-occluded retrograde transvenous obliteration. J Hepatobiliary Pancreat Sci. 2010;17:898–903.

    Article  PubMed  Google Scholar 

  66. Hiraga N, Aikata H, Takaki S, et al. The long-term outcome of patients with bleeding gastric varices after balloon-occluded retrograde transvenous obliteration. J Gastroenterol. 2007;42:663–72.

    Article  PubMed  Google Scholar 

  67. Kitamoto M, Imamura M, Kamada K, et al. Balloon-occluded retrograde transvenous obliteration of gastric fundal varices with hemorrhage. AJR Am J Roentgenol. 2002;178:1167–74.

    Article  PubMed  Google Scholar 

  68. Chikamori F, Kuniyoshi N, Shibuya S, et al. Eight years of experience with transjugular retrograde obliteration for gastric varices with gastrorenal shunts. Surgery. 2001;129:414–20.

    Article  CAS  PubMed  Google Scholar 

  69. Koito K, Namieno T, Nagakawa T, et al. Balloon-occluded retrograde transvenous obliteration for gastric varices with gastrorenal or gastrocaval collaterals. AJR Am J Roentgenol. 1996;167:1317–20.

    Article  CAS  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Edward Wolfgang Lee .

Editor information

Editors and Affiliations

Self Study

Self Study

1.1 Questions

  1. 1.

    Which statement is true?

    1. (a)

      BRTO and modified BRTO is to treat esophageal varices.

    2. (b)

      Gastric variceal bleeding always occurs at the highest portosystemic gradient.

    3. (c)

      CARTO requires sclerosing agent such as EO.

    4. (d)

      TIPS should not be performed in patients with severe hepatic encephalopathy.

  2. 2.

    Which statement is true?

    1. (a)

      BRTO should not be performed in patients with HE as BRTO may worsen HE.

    2. (b)

      BRTO creates a shunt between a portal vein and a hepatic vein.

    3. (c)

      SPSSs can be often seen in patients with cirrhosis and portal hypertension

    4. (d)

      PARTO requires sclerosing agent such as EO

1.2 Answers

  1. 1.

    Which statement is true?

    • (d) TIPS should not be performed in patients with severe hepatic encephalopathy.

  2. 2.

    Which statement is true?

    • (c) SPSSs can be often seen in patients with cirrhosis and portal hypertension

Rights and permissions

Reprints and permissions

Copyright information

© 2020 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Lee, E.W., Hall, D. (2020). Procedure for Gastric Variceal Bleeding: From BRTO to PARTO to CARTO, Three Decades of Progress. In: Radu-Ionita, F., Pyrsopoulos, N., Jinga, M., Tintoiu, I., Sun, Z., Bontas, E. (eds) Liver Diseases. Springer, Cham. https://doi.org/10.1007/978-3-030-24432-3_56

Download citation

  • DOI: https://doi.org/10.1007/978-3-030-24432-3_56

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-030-24431-6

  • Online ISBN: 978-3-030-24432-3

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics